Posts Posts by: "Tim Fell"

LONDON, 6 April 2016 – Synthace Ltd., a London based technology company developing Antha, a high level language and operating system for working with biology, today announced it has entered into a strategic partnership with Microsoft to use Azure cloud analytics, cognitive services, and machine learning. Geoff Hughes, Business Development at Microsoft commented “We are…(Read More)

LONDON, 10 March 2016 – Synthace scientists have published a feature review in Cell Press: Trends in Biotechnology’s special Industrial Biotechnology March 2016 issue entitled “Harnessing QbD, Programming Languages, and Automation for Reproducible Biology”. The paper is open access www.cell.com/trends/biotechnology/fulltext/S0167-7799(15)00246-2 and can be downloaded here…(Read More)

LONDON & NEW YORK, 28 October 2015 – Synthace Ltd., the bioengineering company leveraging multidimensional experimentation and Antha, an unambiguous language to describe process workflows to transform the productivity of biological systems, announced today that it has entered into a new relationship with MSD (known as Merck & Co., Inc., Kenilworth, NJ, USA, in the United…(Read More)

INDIANAPOLIS AND LONDON, UK – (Oct. 1, 2015) – Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announce they have entered into a research collaboration to optimize technology by accelerating development of fermentation-based production of crop protection products. The collaboration includes a multi-seat enterprise license giving…(Read More)